Navigation Links
Mayo Clinic CEO Offers New Vision for Personalized Patient Care
Date:3/4/2009

WASHINGTON, March 4 /PRNewswire/ -- Denis A. Cortese, M.D., president and CEO of the Mayo Clinic, offered a new vision for personalized healthcare in America at a time when Congress and the administration are discussing changes in the healthcare system.

The Mayo Clinic is committed to implementing personalized medicine for its patients. By targeting specific treatments to individual patients based on an analysis of differences in their molecular makeup, personalized medicine increases the effectiveness and safety of many existing therapies and spurs the creation of new treatments.

Dr. Cortese was introduced by Paul Stoffels, M.D., company group chairman, global pharmaceutical research and development, Johnson & Johnson. Dr. Stoffels said that Johnson & Johnson is committed to a personalized approach to medicine, using its broad expertise in healthcare research and development to develop targeted therapies for major diseases.

The keynote address at the Personalized Medicine Coalition's annual luncheon took place against the backdrop of the Obama Administration's health reform summit, which the president announced last week in his address to Congress. Johnson & Johnson sponsored the luncheon, which was held at the National Press Club.

Dr. Cortese discussed how Mayo Clinic's implementation of personalized medicine works in practice and what it means for Mayo's patients. He emphasized the importance of interoperable computerized patient records and communication among different providers in determining the optimal treatments for individual patients.

"Health information technology plays a huge role in synthesizing large amounts of data, creating knowledge that will drive evidence-based decision making," Dr. Cortese said.

These insights should guide spending for two sums in the economic stimulus package: $19.2 billion for health information tech
'/>"/>

SOURCE Personalized Medicine Coalition
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
2. Enobia Completes Target Enrollment in Clinical Trial for Infantile Hypophosphatasia
3. Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform
4. Clinical Research Staffing Firm ASG Acquires CRO Ockham Development Group
5. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
6. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
7. Implicit Licenses Clinical Stage Antibody Program From Lilly
8. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
9. Charlotte Anti-Aging Expo & Symposium Supports Free Clinics
10. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
11. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... (Nasdaq: VIAP ), a biotechnology company focused on ... and metabolic disease, today announced that it has completed ... clinical trial of VIA-2291. ,, The FDG-PET trial ... sites in the US and Canada including Massachusetts General ...
(Date:12/3/2009)... 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief ... http://www.beikebiotech.com ), spoke at a conference on ... 22, 2009. Beike is China,s leading,stem cell research ... The conference, organized by the Indian Podiatry ...
(Date:12/2/2009)... announces that a new market research report ... Drug Discovery Technologies - A Global Update ... http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery has ... every pharmaceutical company,s business strategy. There are ...
(Date:12/2/2009)... , - "Bolstering ... Coinciding with the International ... is hosting an international conference in Libreville,(Gabon) on ... The,conference will be attended by government and state ...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
... Emisphere,Technologies, Inc. (Nasdaq: EMIS ), announced ... on Thursday, May 8, 2008, at the Westin,Governor ... Jersey. The,meeting will begin at 10:00 a.m. EDT., ... Inc. is a biopharmaceutical company that,focuses on a ...
... WallSt.net,s 3-Minute Press Show is,a daily video ... Shows air Monday through Friday on:, ... in-depth interviews with,public company executives on their company ... to provide viewers with insight into a company,s ...
... researchers at ... with internal solutions, REDWOOD CITY, Calif., April 15 ... life science researchers, and,Pfizer Pharmaceuticals, Inc. (NYSE: PFE ... a strategic,partnership today. This new multi-year partnership promotes enterprise-wide,deployment ...
Other Biology Technology:Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008 2Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: NPHC, PECD, PNRR 2Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: NPHC, PECD, PNRR 3Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 2Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 3
(Date:12/3/2009)... and animal species can be likened to emptying a museum ... medicines into the trash, or replacing every local cuisine with ... habitats may not just make the world boring. New research ... for catching some nasty disease. , "Habitat destruction and biodiversity ...
(Date:12/3/2009)... CTRC-AACR San Antonio Breast Cancer Symposium continues to attract ... from industry and academia with the goal of eradicating ... scientists and other professionals will gather at the Henry ... 9-13, 2009. The symposium is a partnership between the ...
(Date:12/3/2009)... a personality change in warmer water, according to an intriguing ... more aggressive. , Experiments with two species of young damselfish ... time that some reef fish are either consistently timid, or ... marked as water temperatures rise. , A slight lift of ...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 1USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 2USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 3Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 1Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 2Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 3Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 1Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 2Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 3Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 4Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 5Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 6Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 7Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 8
... of California, Berkeley, has found that damage to a cell's ... increased expression of a marker recognized by the body's immune ... in an advanced online issue of Nature, shed light on ... - which are able to attack tumors - can differentiate ...
... that 85 percent of embryos transferred during in vitro ... for improving diagnostic techniques to identify viable embryos. , ... the study reviewed seven years of U.S. statistics from ... techniques. Director of the Yale Fertility Center, Pasquale Patrizio, ...
... Institute (VGTI) at Oregon Health & Science University have ... or smallpox outbreaks. The research also sheds new light ... monkeypox is closely related to smallpox. This new information ... 72 cases reported by the Centers for Disease Control ...
Other Biology News:New study finds how cells with damaged DNA alert the immune system 2New study finds how cells with damaged DNA alert the immune system 3Researchers develop new testing methods for potential monkeypox or smallpox outbreak 2Researchers develop new testing methods for potential monkeypox or smallpox outbreak 3
Human PDGF R beta MAb (Clone # PR7212)...
Rabbit Serum New Zealand or California Origin...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... returned to customer conjugation of peptide to KLH protein , ... 102 days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each ...
...
Biology Products: